Biopharma

FlowCam supports a variety of drug formulation development applications

Identify the concentration, size, and types of subvisible and submicron particles present in biopharmaceutical formulations, including protein, cell, and gene therapies with flow imaging microscopy as recommended by USP <1788>.

Gain insight into the sources of particles in biological drug products and optimize formulations and manufacturing processes to minimize and control particle formation and ensure that USP <787> and <788> particle requirements are met.

Stock illustration of antibodies floating

Protein Therapeutics

Stay ahead of protein aggregation during formulation. Detect and control particulates and potential contaminants during manufacturing by monitoring changes in particle size distributions, concentrations, and particle types.

Learn more about protein therapy

Cell Therapy

Monitor concentrations of viable and nonviable cells, cell clusters, and particulate impurities as well as culture growth characteristics of organoids in real-time.

Learn more about cell therapy

Gene Therapy

Detect aggregation of viral vectors such as AAVs, lentiviruses, and retroviruses as well as non-viral therapies like LNPs and exosomes to maximize your drug product’s stability.

Learn more about gene therapy

Stock photo of biotherapeutic vial and syringe

Other Therapeutics

Measure and control particles in formulations of biotherapeutics and drug delivery systems throughout the manufacturing process from the bioreactor to point-of-care.

Learn more